Shaker Investments LLC OH Raises Stake in Iradimed Corporation (NASDAQ:IRMD)

Shaker Investments LLC OH increased its position in Iradimed Corporation (NASDAQ:IRMD) by 0.8% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 29,894 shares of the medical equipment provider’s stock after acquiring an additional 233 shares during the period. Shaker Investments LLC OH’s holdings in Iradimed were worth $1,644,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of IRMD. R Squared Ltd purchased a new position in shares of Iradimed during the 4th quarter worth about $30,000. Huntington National Bank raised its stake in Iradimed by 51.3% during the third quarter. Huntington National Bank now owns 1,487 shares of the medical equipment provider’s stock worth $75,000 after purchasing an additional 504 shares during the period. Gladius Capital Management LP boosted its holdings in shares of Iradimed by 126.6% in the 3rd quarter. Gladius Capital Management LP now owns 1,727 shares of the medical equipment provider’s stock valued at $87,000 after purchasing an additional 965 shares during the last quarter. Quantbot Technologies LP grew its stake in shares of Iradimed by 83.0% during the 3rd quarter. Quantbot Technologies LP now owns 2,320 shares of the medical equipment provider’s stock valued at $117,000 after buying an additional 1,052 shares during the period. Finally, Wilmington Savings Fund Society FSB purchased a new position in shares of Iradimed in the 3rd quarter worth $126,000. Hedge funds and other institutional investors own 92.34% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com downgraded shares of Iradimed from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, February 5th.

Insider Activity at Iradimed

In other Iradimed news, CFO John Glenn sold 2,500 shares of the stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $54.18, for a total transaction of $135,450.00. Following the transaction, the chief financial officer now directly owns 4,383 shares in the company, valued at $237,470.94. This represents a 36.32 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 37.10% of the stock is currently owned by company insiders.

Iradimed Price Performance

NASDAQ:IRMD opened at $60.35 on Tuesday. The firm has a 50-day moving average of $56.77 and a two-hundred day moving average of $51.77. The stock has a market cap of $764.63 million, a P/E ratio of 41.34 and a beta of 0.82. Iradimed Corporation has a 1-year low of $40.18 and a 1-year high of $63.29.

Iradimed Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.